E-LIB Suche - Ergebnisse für: Aoe, Keisuke

1

Characterizing soluble immune checkpoint molecules and TGF-..:

Okita, Riki ; Senoo, Tomoya ; Mimura-Kimura, Yuka...
Scientific Reports. 14 (2024) 1 - p. , 2024

Link: https://doi.org/10.1038/..

2

A randomized phase II study of afatinib alone or combined w..:

Ninomiya, Takashi ; Ishikawa, Nobuhisa ; Kozuki, Toshiyuki...
Lung Cancer. 184 (2023) - p. 107349 , 2023

Link: https://doi.org/10.1016/..

3

Nationwide prospective registry database of patients with n..:

Hasegawa, Seiki ; Shintani, Yasushi ; Takuwa, Teruhisa...
Cancer Science. 115 (2023) 2 - p. 507-528 , 2023

Link: https://doi.org/10.1111/..

4

Pembrolizumab plus chemotherapy in Japanese patients with m..:

Sugawara, Shunichi ; Tanaka, Kentaro ; Imamura, Fumio...
Cancer Science. 114 (2023) 8 - p. 3330-3341 , 2023

Link: https://doi.org/10.1111/..

5

Health Care Resource Use Among Patients with Advanced Non–S..:

Goto, Yasushi ; Kawamura, Kodai ; Fukuhara, Tatsuro...
Current Therapeutic Research. 99 (2023) - p. 100712 , 2023

Link: https://doi.org/10.1016/..

6

Survival of chemo-naïve patients with EGFR mutation-positiv..:

Ninomiya, Takashi ; Nogami, Naoyuki ; Kozuki, Toshiyuki...
Japanese Journal of Clinical Oncology. 51 (2021) 8 - p. 1269-1276 , 2021

Link: https://doi.org/10.1093/..

7

Capmatinib in Japanese patients with MET exon 14 skipping–m..:

Seto, Takashi ; Ohashi, Kadoaki ; Sugawara, Shunichi...
Cancer Science. 112 (2021) 4 - p. 1556-1566 , 2021

Link: https://doi.org/10.1111/..

8

JME-001 phase II trial of first-line combination chemothera..:

Miyamoto, Yosuke ; Kozuki, Toshiyuki ; Aoe, Keisuke...
Journal for ImmunoTherapy of Cancer. 9 (2021) 10 - p. e003288 , 2021

Link: https://doi.org/10.1136/..

9

Clinical Efficacy and Safety of Nivolumab in Japanese Patie..:

Fujimoto, Nobukazu ; Okada, Morihito ; Kijima, Takashi...
JTO Clinical and Research Reports. 2 (2021) 3 - p. 100135 , 2021

Link: https://doi.org/10.1016/..

10

Phase 2 Study of YS110, a Recombinant Humanized Anti-CD26 M..:

Nakagawa, Kazuhiko ; Kijima, Takashi ; Okada, Morihito...
JTO Clinical and Research Reports. 2 (2021) 6 - p. 100178 , 2021

Link: https://doi.org/10.1016/..

11

The role of comprehensive analysis with circulating tumor D..:

Sueoka‐Aragane, Naoko ; Nakashima, Chiho ; Yoshida, Hironori...
Cancer Medicine. 10 (2021) 12 - p. 3873-3885 , 2021

Link: https://doi.org/10.1002/..

12

First‐line pembrolizumab vs chemotherapy in metastatic non‐..:

Satouchi, Miyako ; Nosaki, Kaname ; Takahashi, Toshiaki...
Cancer Science. 112 (2021) 12 - p. 5000-5010 , 2021

Link: https://doi.org/10.1111/..

13

Impact of HER2 expression on EGFR-TKI treatment outcomes in..:

Ohashi, Kadoaki ; Ninomiya, Kiichiro ; Yoshioka, Hiroshige...
Lung Cancer. 150 (2020) - p. 83-89 , 2020

Link: https://doi.org/10.1016/..

14

Real-world effectiveness and safety of nivolumab in patient..:

Morita, Ryo ; Okishio, Kyoichi ; Shimizu, Junichi...
Lung Cancer. 140 (2020) - p. 8-18 , 2020

Link: https://doi.org/10.1016/..

15

Retracted: First‐line pembrolizumab vs chemotherapy in meta..:

Satouchi, Miyako ; Nosaki, Kaname ; Takahashi, Toshiaki...
Cancer Science. 111 (2020) 12 - p. 4480-4489 , 2020

Link: https://doi.org/10.1111/..